NCT05287620Completed
Objective, Passive Assessment of LRRK2 Carriers
Source: ClinicalTrials.gov · Last updated 28 Jun 2024
Brief summary (registry, in English)
The goal of this project is to identify objective, sensitive, and convenient measures for assessing early signs of Parkinson's disease in an at-risk population at home. We will do so by using a wireless sensor and analyzing the radio signals that bounce off patients' bodies, while patients go about their normal life without needing to wear sensors, answer questionnaires, or actively perform any tests.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 10 (actual)
- First submitted
- 9 Mar 2022
- Start date
- 27 Apr 2022
- Primary completion date
- 7 May 2024
- Lead sponsor
- University of Rochester
- Diseases
- Parkinson disease
- NCT number
- NCT05287620
What you commit to
- Study type: Observational
- Participants enrolled: 10
- From 27 Apr 2022 to the primary completion date, 7 May 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Currently taking neuroleptics or other drugs known to cause parkinsonism
Other illness
- Any medical or psychiatric condition that, in the study team's judgement, would preclude participation
- Self-reported or VALOR-PD investigator determined Parkinson's disease
- Any movement disorder (e.g. essential tremor)
Other
- Inability to complete study activities, as determined by the study team
- Pregnancy
- Non-ambulatory status
- More than one ambulatory pet in the household\*
- More than two individuals in the household (not including participant)\*
- these criteria can be waived at the discretion of the investigators
Who the study is looking for
- At least 50 years of age
- Able and willing to provide informed consent
- English fluency
- U.S. resident
- LRRK2 G2019S gene carrier, determined by participation in VALOR-PD
- Mild parkinsonian signs, determined by modified Movement Disorder Society-Unifeid Parkinson's Disease Rating Scale (MDS-UPDRS) score from the most recent VALOR-PD visit
- Have WiFi in their residence
- Access to a smartphone or tablet
Age in the registry: 50 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Rochester Coordinator of this site? Confirm its status | Rochester | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.